Lipopolysaccharide primes macrophages to increase nitric oxide production in response to Staphylococcus Aureus

Immunology Letters

Volumn 112, Issue 2, 2007, Pages 75-81

  Zhu, Xiaoyan ^a   Liu, Yujian ^a   Liu, Shujuan ^a   Diao, Fei ^a   Xu, Renbao ^a   Ni, Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Lipopolysaccharide; Nitric oxide; Priming; Staphylococcus aureus

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALCINEURIN; CYCLOSPORIN A; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; CALCINEURIN; CARBAZOLES; CELL LINE; CYCLOSPORINE; HUMANS; IMIDAZOLES; INDOLES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PYRIDINES; SEPSIS; STAPHYLOCOCCUS AUREUS;

EID: 34548489609     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.06.007     Document Type: Article

References (34)

1. Ulloa L., and Tracey K.J. The "cytokine profile": a code for sepsis. Trends Mol Med 11 (2005) 56-63
2. Bone R.C. Gram-negative sepsis: background, clinical feature, and intervention. Chest 100 (1991) 802-808
3. McGowan J. Increasing threat of Gram-positive bacterial infections in the intensive care unit setting. Crit Care Med 29 (2001) N69-N74
4. Wheller A.P., and Bernard G.R. Treating patients with severe sepsis. N Engl J Med 340 (1999) 207-214
5. Javaloyas M., Garcia-Somoza D., and Gudiol F. Epidemiology and prognosis of bacteremia: a 10-y study in a community hospital. Scand J Infect Dis 34 (2002) 436-441
6. Weinstein M.P., Towns M.L., Quartey S.M., Mirrett S., Reimer L.G., Parmigiani G., et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24 (1997) 584-602
7. Wray G.M., Foster S.J., Hinds C.J., and Thiemermann C. A cell wall component from pathogenic and non-pathogenic Gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of tumour necrosis factor-alpha, nitric oxide production, shock, and multiple organ injury/dysfunction in the rat. Shock 15 (2001) 135-142
8. Tsiotou A.G., Sakorafas G.H., Anagnostopoulos G., and Bramis J. Septic shock; current pathogenetic concepts from a clinical perspective. Med Sci Monit 11 (2005) RA76-RA85
9. Vincent J.L., Zhang H., Szabo C., and Preiser J.C. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 161 (2000) 1781-1785
10. Han S.H., Kim J.H., Seo H.S., Martin M.H., Chung G.H., Michalek S.M., et al. Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2. J Immunol 176 (2006) 573-579
11. Florquin S., Amraoui Z., Dubois C., Decuyper J., and Goldman M. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med 180 (1994) 1153-1158
12. Peck O.M., Williams D.L., Breuel K.F., Kalbfleisch J.H., Fan H., Tempel G.E., et al. Differential regulation of cytokine and chemokine production in lipopolysaccharide-induced tolerance and priming. Cytokine 26 (2004) 202-208
13. Peck O.M., Fan H., Tempel G.E., Teti G., Halushka P.V., and Cook J.A. Staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: role of interferon-gamma. Shock 21 (2004) 254-260
14. Fan H., and Cook J.A. Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 10 (2004) 71-84
15. Condliffe A.M., Kitchen E., and Chilvers E.R. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 94 (1998) 461-471
16. Su S.C., Hua K.F., Lee H., Chao L.K., Tan S.K., Lee H., et al. LTA and LPS mediated activation of protein kinases in the regulation of inflammatory cytokines expression in macrophages. Clin Chim Acta 374 (2006) 106-115
17. Castrillo A., Pennington D.J., Otto F., Parker P.J., Owen M.J., and Bosca L. Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection. J Exp Med 194 (2001) 1231-1242
18. Boyd J.H., Divangahi M., Yahiaoui L., Gvozdic D., Qureshi S., and Petrof B.J. Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin. Infect Immun 74 (2006) 6829-6838
19. Kano H., Doi T., Fujita Y., Takimoto H., Yano I., and Kumazawa Y. Serotype-specific modulation of human monocyte functions by glycopeptidolipid (GPL) isolated from Mycobacterium avium complex. Biol Pharm Bull 28 (2005) 335-339
20. Hsu D.Z., Wang S.T., Deng J.F., and Liu M.Y. Epinephrine protects against severe acute gastric bleeding in rats: role of nitric oxide and glutathione. Shock 23 (2005) 253-257
21. Lehner M.D., Morath S., Michelsen K.S., Schumann R.R., and Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 166 (2001) 5161-5167
22. Peck O.M., Zingarelli B., Fan H., Teti G., Tempel G., Halushka P.V., et al. The phosphatidylinositol 3 kinase pathway regulates tolerance to lipopolysaccharide and priming responses to Staphylococcus aureus and lipopolysaccharide. Shock 26 (2006) 31-36
23. Obasanjo-Blackshire K., Mesquita R., Jabr R.I., Molkentin J.D., Hart S.L., Marber M.S., et al. Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase. Cardiovasc Res 71 (2006) 672-683
24. Zhu Y.N., Yang Y.F., Ono S., Zhong X.G., Feng Y.H., Ren Y.X., et al. Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-gamma is associated with the activation of extracellular signal-related kinase. Int Immunol 18 (2006) 981-990
25. Kim S.H., Kim J., and Sharma R.P. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol Res 49 (2004) 433-439
26. Rusnak F., and Mertz P. Calcineurin: form and function. Physiol Rev 80 (2000) 1483-1521
27. Kengatharan K.M., Kimpe S.D., Robson C., Foster S.J., and Thiemermann C. Mechanism of Gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med 188 (1998) 305-315
28. Crabtree G.R. Calcium, calcineurin, and the control of transcription. J Biol Chem 276 (2001) 2313-2316
29. 2+ - and protein kinase C-dependent signaling pathway for nuclear factor-kappaB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages. J Biol Chem 281 (2006) 31337-31347
30. 2+/calmodulin-dependent protein phosphatase calcineurin mediates the expression of iNOS through IKK and NF-kappaB activity in LPS-stimulated mouse peritoneal macrophages and RAW 264.7 cells. Biochem Biophys Res Commun 314 (2004) 695-703
31. Bergeron Y., Ouellet N., Simard M., Olivier M., and Bergeron M.G. Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-l-arginine. Antimicrob Agents Chemother 43 (1999) 2283-2290
32. Teale D.M., and Atkinson A.M. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 30 (1992) 839-842
33. Tsai W.C., Strieter R.M., Zisman D.A., Wilkowski J.M., Bucknell K.A., Chen G.H., et al. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect Immun 65 (1997) 1870-1875
34. Bakker J., Grover R., McLuckie A., Holzapfel L., Andersson J., Lodato R., et al. Administration of the nitric oxide synthase inhibitor N(G)-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 32 (2004) 1-12